Apr 1, 2026 | Blog
Africa carries roughly a quarter of the world’s disease burden, yet in 2023 just 1.1% of clinical trials initiated globally were hosted on the continent (1). The infrastructure argument, regulatory gaps, ethics review timelines, laboratory Capaci, is familiar...
Mar 25, 2026 | Blog
Clinical trials remain essential to medical evidence generation. They are critical for establishing whether new interventions are safe and effective under controlled conditions. But for African health systems and life sciences strategy, trial data alone is not enough....
Mar 24, 2026 | Blog
World TB Day: Ending Tuberculosis Requires Science, Not Just Treatment Each year on 24 March, World TB Day draws attention to tuberculosis (TB), which remains one of the world’s deadliest infectious diseases. In 2024, an estimated 10.7 million people fell ill with TB...
Mar 20, 2026 | Article
For decades, Africa has often been portrayed as a continent trying to “catch up” with the rest of the world in science, healthcare, and innovation. But a growing movement among African scientists, institutions, and global partners suggests a different narrative...
Mar 19, 2026 | Blog
Africa is still too often brought into drug and vaccine development late, most commonly during Phase III, post-marketing, or implementation studies. Scientifically, that is a weak model. Phase I and II studies are where development programmes establish core...
Mar 18, 2026 | Blog
Women remain underrepresented in Africa’s research workforce overall, and they are even less visible in senior academic and scientific leadership roles. UNESCO’s latest figures show that women account for about 32% of researchers in sub-Saharan Africa, although...
Mar 13, 2026 | Blog
Ethics in clinical research has never been a matter of paperwork alone. Yet in practice, ethical quality is still too often judged by whether the right forms were signed, the right approvals were secured, and the protocol was followed on paper. Across African research...
Mar 11, 2026 | Blog
Across Africa, something subtle but important is changing in the way leaders talk about health. For many years, health systems across the continent were largely framed through the lens of global solidarity: donor programs, development assistance, and externally...
Mar 11, 2026 | Blog
When we discuss the advancement of clinical trials in Africa, the conversation often gravitates toward infrastructure: genomic sequencing capacity, biobanking facilities, or electronic data capture systems. While these physical assets are vital, there is an equally...
Mar 10, 2026 | Blog
Global health rhetoric is rich with good intentions. Few terms have been as enduring or as poorly interrogated, as “capacity building”. For decades, it has served as a justification for donor spending, a line item in pharmaceutical industry corporate...
